Last reviewed: July 15, 2026
Last updated: July 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide is often described as an appetite suppressant, but clinical evidence shows it delivers fat loss through multiple metabolic pathways. Beyond making you feel fuller faster, tirzepatide activates both GLP-1 and GIP receptors—two distinct hormone systems that increase energy expenditure and promote fat tissue breakdown.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
The Dual Receptor Mechanism: More Than Just Hunger Reduction
Tirzepatide binds to two hormone receptors: GLP-1 and GIP. This dual action distinguishes it from single-pathway medications like semaglutide, which targets only GLP-1. The GLP-1 pathway slows stomach emptying and signals fullness to your brain, while the GIP pathway directly increases insulin sensitivity and modulates glucose metabolism. Together, these pathways work on your central nervous system, digestive system, and metabolic tissues simultaneously.
Clinical trials show that patients on tirzepatide experience metabolic changes beyond appetite suppression. Studies document measurable increases in resting energy expenditure—the calories your body burns at rest—along with enhanced fat oxidation during physical activity. This means your metabolism is working harder even when you're sitting still, a mechanism distinct from simply eating less.
Increased Fat Oxidation and Energy Expenditure
Fat oxidation refers to your body's ability to break down and use stored fat as fuel. Tirzepatide enhances this process through GIP receptor activation, which improves mitochondrial function in muscle and fat cells. When mitochondria—your cells' energy factories—work more efficiently, they burn more calories from fat stores. This metabolic shift is measurable in clinical studies tracking respiratory quotient and substrate utilization.
Research participants using tirzepatide show sustained increases in 24-hour energy expenditure compared to placebo. This elevated metabolic rate persists across different activity levels, meaning the fat-burning effect occurs during exercise, daily tasks, and rest. The magnitude of this metabolic boost contributes significantly to weight loss, independent of dietary changes alone.
Insulin Sensitivity and Metabolic Efficiency
Tirzepatide improves how your cells respond to insulin, a hormone that controls blood sugar and fat storage. When insulin sensitivity improves, your body becomes more efficient at directing nutrients toward muscle and away from fat accumulation. The GIP component of tirzepatide is particularly effective at enhancing insulin secretion in response to meals, which helps prevent blood sugar spikes that trigger fat storage signals.
Better insulin sensitivity also reduces chronic inflammation linked to obesity and metabolic dysfunction. Lower inflammation levels support faster fat loss and improve overall metabolic health. Clinical data shows tirzepatide users achieve improvements in hemoglobin A1C, fasting glucose, and triglyceride levels—markers of metabolic function that directly correlate with the body's capacity to burn fat efficiently.
Personalized Fat Loss: The Role of Genetic Variations
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
The PlexusDx Precision Peptide Genetic Test analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
If tirzepatide burns fat through metabolism, do I still need to change my diet?
Tirzepatide enhances your body's fat-burning capacity, but combining it with balanced nutrition accelerates results. Most patients report naturally eating smaller portions and craving less due to improved satiety signals. PlexusDx providers recommend moderate dietary adjustments rather than restrictive dieting, allowing tirzepatide's metabolic benefits to do the primary work.
How quickly does tirzepatide increase metabolic rate?
No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
What is the cost of compounded tirzepatide at PlexusDx?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is compounded tirzepatide as effective as brand-name Mounjaro?
PlexusDx tirzepatide is prepared by licensed 503A compounding pharmacies using the same active pharmaceutical ingredient as brand medications. Compounded versions offer identical metabolic and fat-burning mechanisms. The key difference is access and affordability—PlexusDx serves all 50 states without insurance requirements, making personalized fat-loss therapy available to more patients.
How does the Precision Peptide Genetic Test improve my fat-loss results?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Maximizing Your Mounjaro Journey: What Foods Should You Eat for Optimal Results and Lasting Wellness
Is the FDA Going to Approve Mounjaro for Weight Loss?